Logo UCA
Icon P.S.
Retour à l'ouvrage

Informations du chercheur

Nom complet

Belbaraka rhizlane

Grade

PES

Spécialité

oncologie

Thématique de recherche

santé

Laboratoire

Laboratoire Biosciences et santé

Établissement

Faculté de Médecine et de Pharmacie de Marrakech

Projets (0 au total)

Aucun projet disponible.

Publications (47 au total)

What does it take to conduct clinical trials in African countries? Insights from Morocco

Auteur: Nada Benhima, Mohamed El Fadli, Ismail Essâdi, Rhizlane Belbaraka

Revue: ecancermedicalscience

Année: 2022

DOI: 10.3332/ecancer.2022.1411

Incidence Trends of Cancer in Morocco: The Tale of the Oncological Center of Marrakech (Morocco) over 8 Years

Auteur: Rhizlane Belbaraka, Nada Benhima, Ahmed Laatabi, Mohammed El Fadli, Ismail Essâdi

Revue: Journal of Cancer Epidemiology

Année: 2022

DOI: 10.1155/2022/3307194

An Open-Label, Multinational, Multicenter, Phase IIIb Study with Subcutaneous Administration of Trastuzumab in Patients with HER2-Positive Early Breast Cancer to Evaluate Patient Satisfaction

Auteur: İrfan Cicin, Mohammed Oukkal, Hassen Mahfouf, Amel Mezlini, Blaha Larbaoui, Slim Ben Ahmed, Hassan Errihani, Khalid Alsaleh, Rhizlane Belbaraka, Perran Fulden Yumuk, Burce Goktas, Mustafa Özgüroğlu

Revue: European Journal of Breast Health

Année: 2022

DOI: 10.4274/ejbh.galenos.2021.2021-9-9

Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer

Auteur: D. Miles, J. Gligorov, F. André, D. Cameron, A. Schneeweiss, C. Barrios, B. Xu, A. Wardley, D. Kaen, L. Andrade, V. Semiglazov, M. Reinisch, S. Patel, M. Patre, L. Morales, S.L. Patel, M. Kaul, T. Barata, J. O’Shaughnessy, Q. Zhang, B. Xu, Z. Shao, X. Wang, C. Geng, X. Yan, Z. Tong, K. Shen, Y. Yin, T. Sun, J. Yang, J. Feng, M. Yan, Y. Wang, Q. Liu, S. Zhang, M. De Laurentiis, A. Santoro, V. Guarneri, M. Colleoni, C. Natoli, L. Cortesi, S. Placido, L. Gianni, F. Ferrau, L. Livi, A. Zambelli, L. Del Mastro, G. Tonini, F. Montemurro, G. Bianchi, R. Pedersini, S. Prete, G. Allegrini, G. Naso, P. Vici, D. Loirat, A. Mailliez, F. Priou, O. Tredan, F. Dalenc, C. Perrin, J. Gligorov, M. Timar David, N. Dohollou, L. Teixeira, F. Brocard, A. Arnaud, S. Delaloge, J.-P. Spano, L. Mansi, L. Andrade, F. Damian, J. Pedrini, S. Aleixo, R. Hegg, R. Junior, M. Reinisch, M. Schmidt, C. Wenzel, E.-M. Grischke, A. Schneeweiss, M. Just, N. Harbeck, C. Schumacher, U. Peters, D. Fischer, H. Forstbauer, R. Liersch, E. Warner, N. Bouganim, C. Doyle, J. Price Hiller, T. Vandenberg, M. Pavic, A. Robinson, G. Roldan Urgoiti, N. Califaretti, A. Alacacioglu, M. Gumus, B. Yalcin, I. Cicin, F. Kose, K. Uygun, M. Kaplan, E. Cubukcu, A. Wardley, M. Harries, D. Miles, D. Doval, S. Gupta, P. Mohapatra, S. Chatterjee, N. Ghadyalpatil, M. Singhal, S. Nag, A. Agarwal, I. Wolf, E. Gal Yam, R. Yerushalmi, T. Peretz, G. Fried, N. Ben Baruch, D. Katz, E. Hamilton, F. Kayali, A. Brufsky, M. Telli, G. Wright, R. Oyola, T. Rakowski, S. Graff, S. Tjulandin, V. Semiglazov, A. Aparicio, M. Ruiz Borrego, L. Merino, J. Guerra Martinez, E. Lopez, T. Yamashita, S. Ohtani, K. Inoue, Y. Ito, N. Niikura, T. Nakayama, Y. Sagara, Y. Yanagita, Y. Kamada, K. Kaneko, D. Kaen, A. Nervo, A. Eniu, M. Schenker, P. Priester, B. Melichar, M. Zimovjanova, P. Sormova, J. Sufliarsky, M. Kakalejcik, R. Belbaraka, H. Errihani, D. Le Than, D. Pham, G. Aravantinos, C. Papadimitriou, G. Koumakis, C. Papandreou, P. Podolski, K. Tabane

Revue: Annals of Oncology

Année: 2021

DOI: 10.1016/j.annonc.2021.05.801

Repurposing anticancer drugs for the management of COVID-19

Auteur: Khalid El Bairi, Dario Trapani, Angelica Petrillo, Cécile Le Page, Hanaa Zbakh, Bruno Daniele, Rhizlane Belbaraka, Giuseppe Curigliano, Said Afqir

Revue: European Journal of Cancer

Année: 2020

DOI: 10.1016/j.ejca.2020.09.014

Impact of tumor location (right vs left) as a prognostic and

Auteur: Mohamed Elfadli, Nada Benhima, Rhizlane BELBARAKA

Revue: annals of Oncology

Année: 2020

DOI: https://doi.org/10.1016/j.annonc.2020.04.397

Gastrointestinal stromal tumors: 10 years of experience in the

Auteur: M. Kaakoua, N. Benhima, R. BELBARAKA

Revue: Annals of Oncology

Année: 2020

DOI: https://doi.org/10.1016/j.annonc.2020.04.383

Repurposing anticancer drugs for the management of COVID-19

Auteur: KhalidEl Bairi a, DarioTrapani b, Angelica Petrillo c, Cécile Le Page e, Hanaa Zbakh f, Bruno Daniel e, Rhizlane Belbaraka g, Giuseppe Curigliano b h, Said Afqir a

Revue: European Journal of Cancer,

Année: 2020

DOI: https://doi.org/10.1016/j.ejca.2020.09.014

Tolerablity of everolimus in clinical practice: A retrospective study | Tolérance de l’évérolimus en pratique clinique: Étude retrospective

Auteur: Afani, L., Belbaraka, R., Awada, A.

Revue: Pan African Medical Journal,

Année: 2020

DOI: 10.11604/pamj.2020.36.26.16580

Communications (25 au total)

Cancer de la prostate: place du Zoladex à l'ère des nouvelles thérapies

Manifestation: 31ème Congrès National d'Urologie

Date: 2024-05-11

Organisation: Marrakech

Interventional Oncology Trials in Africa Then, Now and Next

Manifestation: AORTIC 2023: Cancer in Africa: Implementation, Workforce, Opportunities

Date: 2023-11-05

Organisation: DAKAR, SENEGAL

Breast Cancer: Improving the Patient Journey in Morocco

Manifestation: AORTIC 2023: Cancer in Africa: Implementation, Workforce, Opportunities

Date: 2023-11-04

Organisation: DAKAR, Senegal

Risk factors, and prognostic factors, for progression free survival in patients with newly diagnosed of lung cancer: a population-based study

Manifestation: Congrès de l' Association Marocaine de Formation et Recherche en Oncologie Médicale

Date: 2023-10-06

Organisation: Tanger

Controversies in Lung Cancer: which second line after platinum based chemotherapy?

Manifestation: Congrès de l'Association Marocaine de Formation et Recherche en Oncologie Médicale

Date: 2023-10-06

Organisation: Tanger

An AI mobile health app for remote support and monitoring of breast cancer patients undergoing chemotherapy (Hna Maak).

Manifestation: 6ème édition Forum Galien

Date: 2023-10-03

Organisation: Dakar- Senegal

Development and validation of a predictive tool for oesophageal cancer patients: A Moroccan-based study.

Manifestation: 25th World Congress on Gastrointestinal Cancer

Date: 2023-06-29

Organisation: Barcelone- Espagne

Nouveautés dans le cancer du sein triple négatif et Her 2 low

Manifestation: 1st Maghreb Summit Astra Zeneca

Date: 2023-02-25

Organisation: Tunis, Tunisie

An AI mobile health app for remote support and monitoring of breast cancer patients undergoing chemotherapy.

Manifestation: 2ème édition du congrès Healthcare et Innovation

Date: 2023-02-23

Organisation: Casablanca